New Study Supports the Combination of an Excimer Laser and an Oral JAK Inhibitor in Non-segmental Vitiligo
The combination of a 308nm excimer laser with an oral Janus kinase (JAK) inhibitor may demonstrate “superior efficacy, unprecedented response rates, and excellent safety” relative to monotherapy or conventional treatment in adults with non-segmental vitiligo, a study in the International Journal of Dermatology shows.